OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™
SOPHiA GENETICS Announces L’hôpital Universitaire Avicenne is Live on SOPHiA DDM™
read more
Christophe Pignol
Webinar Series – Episode 2: Decoding Complexity: Advanced Techniques for Detecting Low Allele Frequency Variants
Decoding Complexity – Overcoming Real-World Challenges in Variant Analysis Join us for the second...
Unlocking precision medicine through high-throughput sequencing in pharmacogenetics: RNPGx experience
Join us for an enlightening webinar on the evolution of pharmacogenetics, from its historical...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™
Society of Genetics of Brazil Congress
The SBG Congress in Brazil, organized by the Brazilian Society of Genetics is a prestigious event...
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024
BOSTON, United States and ROLLE, Switzerland, July 23, 2024 — SOPHiA GENETICS (Nasdaq: SOPH), a...
World Clinical Biomarkers & CDx Boston
We’re back at World Clinical Biomarkers & CDx Boston! Join us to explore how you...
ASCO 2024
ASCO is back! We can’t wait to meet you at booth #11099, June 1-3. Meet our BioPharma team to...
Tri-Con 2024
SOPHiA GENETICS™ is excited to be a part of the 31st International Precision Med Tri-Con...
Addressing pharmacogenetics in routine NGS workflows
At SOPHiA GENETICS, we collaborate with genetic experts to develop specialized next-generation...
USCAP 2024
SOPHiA GENETICS™ is excited to be a part of the 113th United States and Canadian Academy of...
ACMG 2024
[dsm_button _builder_version="4.24.2" _module_preset="default" theme_builder_area="et_body_layout"...